Skip to main navigation Skip to search Skip to main content

Epstein Barr virus associated membrane reactive antibodies during long term survival after Burkitt's lymphoma

  • P. Gunven
  • , G. Klein
  • , P. Clifford
  • , S. Singh

Research output: Contribution to journal › Article › peer-review

20 Scopus citations

Abstract

Antibodies to Epstein Barr virus associated cell membrane antigens persisted or slowly decreased during prolonged uncomplicated survival of patients with Burkitt's lymphoma in remission. Serum was sampled from 4 patients within 6 mth before recurrence occurring after the first yr and preceded by remission during more than 6 mth. Rapid and significant decreases of the antibodies before clinical recognition of the recurrences were found in 3 patients. The fourth patient had slowly increasing titers before relapse. Immune stimulant treatment during remission, with Bacille Calmette Guerin vaccine (BCG) or BCG + Bordetella pertussis, temporarily increased the antibody levels. Possible mechanisms for the observed titer changes before recurrence are discussed.

Original languageEnglish
Pages (from-to)1422-1426
Number of pages5
JournalProceedings of the National Academy of Sciences of the United States of America
Volume71
Issue number4
DOIs
StatePublished - 1974
Externally publishedYes

Fingerprint

Dive into the research topics of 'Epstein Barr virus associated membrane reactive antibodies during long term survival after Burkitt's lymphoma'. Together they form a unique fingerprint.

Cite this